Bevacizumab (Avastin) for Neurofibromatosis Type 2 (NF2) associated acoustic neuromas

Type: drug

Status: Approved (for other cancers)

Developer: Genentech

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026